<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02947607</url>
  </required_header>
  <id_info>
    <org_study_id>s57084</org_study_id>
    <nct_id>NCT02947607</nct_id>
  </id_info>
  <brief_title>Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma</brief_title>
  <official_title>Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen Pharmaceutica N.V., Belgium</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the investigation of new host-microbiome interactions promoting
      adenoma formation and adenocarcinoma progression. For that purpose, the investigators will
      collect saliva, stool and colon biopsy specimens from patients referred to colonoscopy or
      surgical resection of colorectal tumor. Besides, a questionnaire about diet, lifestyle and
      medical history will be collected. Sample analysis will involve simultaneous characterization
      of host and microbiota genomic and transcriptomic components.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differential host microbiome composition and abundance in healthy, adenoma and CRC patients and its correlation to CRC risk features and host genomic and transcriptomic components.</measure>
    <time_frame>2 years</time_frame>
    <description>Host microbiome composition and abundance data will be generated from saliva, stool and colonic biopsies with amplicon-based 16S ribosomal RNA sequencing. This data will be correlated to CRC risk factors collected in a questionnaire covering lifestyle, diet and medical history as well as host genomic and transcriptomic profiling generated by targeted gene sequencing and microarray-based gene expression profiling.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1125</enrollment>
  <condition>Colorectal Adenoma and Carcinoma</condition>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
    <description>Patients undergoing lower GI endoscopy without any colorectal adenoma or carcinoma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adenoma</arm_group_label>
    <description>Patients undergoing lower GI endoscopy with presence of colorectal adenoma detected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colorectal cancer</arm_group_label>
    <description>Patients diagnosed with colorectal cancer and referred to surgical carcinoma resection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colon biopsies</intervention_name>
    <arm_group_label>Healthy control</arm_group_label>
    <arm_group_label>Adenoma</arm_group_label>
    <arm_group_label>Colorectal cancer</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva Stool Tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study participants are patients with CRC that will undergo surgical tumor resection or
        patients referred for lower GI endoscopy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Lower GI endoscopy patients

        Inclusion Criteria:

          -  Participant is willing and able to give informed consent for the participation in the
             study before any protocol-specific screening procedures are performed

          -  Male or female, aged 18 years or above

          -  Referred to lower GI endoscopy. Referral reasons can be among others:

               -  Positive FOBT (Fecal Occult Blood Test)

               -  Follow up after polypectomy

               -  Screening because of age

               -  Bleeding

               -  Abdominal pain

               -  Familial or past history of colon cancer or adenoma

               -  Abnormal imaging such as barium enema

               -  Change in bowel habits

          -  Both self-referrals, referrals from external GP or specialists and internal referrals
             can be included.

        Exclusion Criteria:

          -  Previous diagnosis of an inflammatory bowel disease

          -  Previous diagnosis of intestinal polyposis syndrome

        CRC patients

        Inclusion criteria:

          -  Participant is willing and able to give informed consent for the participation in the
             study before any protocol-specific screening procedures are performed

          -  Male or female, aged 18 years or above

          -  Diagnosis of CRC for which resection is planned

          -  Both internal and external referrals from specialists can be included

        Exclusion Criteria:

          -  Previous diagnosis of an inflammatory bowel disease

          -  Previous diagnosis of intestinal polyposis syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sabine Tejpar, Prof. Dr.</last_name>
    <phone>+32 16 345512</phone>
    <email>sabine.tejpar@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitaire Ziekenhuizen Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Flemish Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Verbandt, MSc</last_name>
      <phone>+16343490</phone>
      <email>sara.verbandt@kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Vanessa Vangeel</last_name>
      <phone>+16342596</phone>
      <email>vanessa.vangeel@uzleuven.be</email>
    </contact_backup>
    <investigator>
      <last_name>Sabine Tejpar, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maxime Bronzwaer, MD</last_name>
      <phone>+31 20 566 6464</phone>
      <email>m.e.bronzwaer@amc.uva.nl</email>
    </contact>
    <contact_backup>
      <last_name>Aukje Munnik, MSc</last_name>
      <phone>+31 20 566 4109</phone>
      <email>a.munnik@amc.uva.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Evelien Dekker, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2016</study_first_submitted>
  <study_first_submitted_qc>October 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2016</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Human gut microbiome</keyword>
  <keyword>Colorectal cancer</keyword>
  <keyword>Colorectal adenoma</keyword>
  <keyword>Gut bacteria</keyword>
  <keyword>Metagenomics</keyword>
  <keyword>Metatranscriptomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

